Chapter CSB 2

Chapter CSB 2

ADDITIONS TO SCHEDULES IN SS. 961.14,
961.16, 961.18, 961.20 AND 961.22, STATS.

CSB 2.001   Addition of Methiopropamine to schedule I.

CSB 2.002   Excluding Fenfluramine from schedule IV.

CSB 2.003   Transfer of Flualprazolam and addition of 4 other synthetic Benzodiazepine substances to schedule I.

CSB 2.004   Addition of Zuranolone to Schedule IV.

CSB 2.005   Addition of 9 Fentanyl Related Substances to Schedule I.

CSB 2.006   Adding 5 Synthetic Cannabinoids to Schedule I.

CSB 2.007   Addition of ADB-BUTINACA, alpha-PiHP, and 3-MMC to Schedule I.

CSB 2.008   Addition of 2-Methyl AP-237 to Schedule I.

CSB 2.009   Addition of 2 Synthetic Benzimidazole-Opioids to Schedule I.

Ch. CSB 2 Note Note: Chapter CSB 2 (except CSB 2 (title)) was renumbered chapter CSB 2 Appendix under s. 13.92 (4) (b) 1., Stats., Register April 2023 No. 808. The appendix is printed at the end of this chapter and contains scheduling actions of the Controlled Substances Board prior to April 3, 2023, which used two-digit numbering ending with s. CSB 2.99. Scheduling actions on or after April 3, 2023, beginning with s. CSB 2.001, are printed below.

CSB 2.001 CSB 2.001 Addition of Methiopropamine to schedule I. Section 961.14 (7) (t), Stats., is created to read:

961.14 (7) (t) N-methyl-1-(thiophen-2-yl)propan-2-amine, commonly known as Methiopropamine.

CSB 2.001 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register April 2023 No. 808, eff. 4-3-23.

CSB 2.002 CSB 2.002 Excluding Fenfluramine from schedule IV. Section 961.20 (4) (am), Stats., is repealed.

CSB 2.002 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register April 2023 No. 808, eff. 4-17-23; correction made under s. 35.17, Stats., Register April 2023 No. 808.

CSB 2.003 CSB 2.003 Transfer of Flualprazolam and addition of 4 other synthetic Benzodiazepine substances to schedule I.

CSB 2.003(1) (1) Section 961.20 (2) (ef), Stats., is repealed.

CSB 2.003(2) (2) Section 961.14 (5) (aa), (ab), (ac), (ad), and (ae), Stats., are created to read:

961.14 (5) (aa) Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4 H -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine).

(ab) Diclazepam (7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2 H -benzo[ e][1,4]diazepin-2-one).

(ac) Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6 H -thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine).

(ad) Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4 H -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine).

(ae) Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methly-4 H -benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine).

CSB 2.003 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register September 2023 No. 813, eff. 9-25-23; correction in (2) made under s. 35.17, Stats., Register September 2023 No. 813.

CSB 2.004 CSB 2.004 Addition of Zuranolone to Schedule IV. Section 961.20 (2) (r), Stats., is created to read:

961.20 (2) (r) Zuranolone.

CSB 2.004 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register February 2024 No. 818, eff. 2-5-24; correction in numbering of CSB 2.004 made under s. 13.92 (4) (b) 1., Stats., Register February 2024 No. 818.

CSB 2.005 CSB 2.005 Addition of 9 Fentanyl Related Substances to Schedule I.

CSB 2.005(1) (1) Section 961.14 (2) (nd) 3m., 10m., 11m., 12e., 12m., 12s., 16n., 17g., and 17r., are created to read:

961.14 (2) (nd) 3m. Alpha’-methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);

10m. 2’,5’-dimethoxyfentanyl (N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide);

11m. 3-furanyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide);

12e. Isovaleryl fentanyl (3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);

12m. Meta-fluorofentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide);

12s. Meta-fluoroisobutyryl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);

16n. Ortho-fluorofuranyl fentanyl (N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);

17g. Para-methoxyfuranyl fentanyl (N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);

17r. Para-methylcyclopropyl fentanyl (N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide);

CSB 2.005 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register February 2024 No. 818, eff. 2-5-24.

CSB 2.006 CSB 2.006 Adding 5 Synthetic Cannabinoids to Schedule I.

CSB 2.006(1) (1) Section 961.14 (4) (tb) 54. to 58., Stats., are created to read:

961.14 (4) (tb) 54. Methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate, commonly known as MDMB-4en-PINACA.

55. Methyl 2-[[1-(4-fluorobutyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate, commonly known as 4F-MDMB-BUTICA or 4F-MDMB-BICA.

56. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(pent-4-en-1-yl)-1H-indazole-3-carboxaminde, commonly known as ADB-4en-PINACA.

57. 5-Pentyl-2-(2-phenylpropan-2-yl)pyrido[4,3-b]indol-1-one, commonly known as CUMYL-PEGACLONE or SGT-151.

58. Ethyl 2-[[1-(5-fluoropentyl)indole-3-carbonyl]amino]-3,3-dimethyl-butanoate, commonly known as 5F-EDMB-PICA or 5F-EDMB-2201.

CSB 2.006 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register February 2024 No. 818, eff. 2-5-24.

CSB 2.007 CSB 2.007 Addition of ADB-BUTINACA, alpha-PiHP, and 3-MMC to Schedule I.

CSB 2.007(1) (1) Section 961.14 (4) (tb) 32m. is created to read:

961.14 (4) (tb) 32m. N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-butyl-1H-indazole-3-carboxamide, commonly known as ADB-BUTINACA.

CSB 2.007(2) (2) Section 961.14 (7) (L) 2m. and 36m. are created to read:

961.14 (7) (L) 2m. 3-methylmethcathinone or 2-(methylamino)-1-(3-methylphenyl)propan-1-one, commonly known as 3-MMC.

36m. 4-methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one, commonly known as alpha-PiHP.

CSB 2.007 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register June 2024 No. 822, eff. 6-17-24; correction in (title) made under s. 13.92 (4) (b) 2., Stats., Register June 2024 No. 822.

CSB 2.008 CSB 2.008 Addition of 2-Methyl AP-237 to Schedule I. Section 961.14 (2) (qz), Stats., is created to read:

961.14 (2) (qz) 2-methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one);

CSB 2.008 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register June 2024 No. 822, eff. 5-20-24; correction made under s. 35.17, Stats., Register June 2024 No. 822.

CSB 2.009 CSB 2.009 Addition of 2 Synthetic Benzimidazole-Opioids to Schedule I. Section 961.14 (2) (xm) 7e. and 7m., Stats., are created to read:

961.14 (2) (xm) 7e. N-desethyl isotonitazene (N-ethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine).

961.14 (2) (xm) 7m. N-piperidinyl etonitazene also known as etonitazepipne (2-(4-ethoxybenzyl)-5-nitro-1-(2-(piperidin-1-yl)ethyl)-1H-benzimidazole).

CSB 2.009 History History: cr. Affirmative action order under s. 961.11 (4), Stats., Register October 2024 No. 826, eff. 10-21-24.

APPENDIX

CSB 2.009 Note Note: This Appendix contains actions of the Controlled Substances Board that were made prior to April 3, 2023, which were numbered ss. CSB 2.01 to 2.99.

CSB 2.009 Note CSB 2.01 Addition of methaqualone to schedule II. The substance known as methaqualone is hereby added to s. 161.16, Stats., schedule II in sub. (6) which subsection is hereby created.

CSB 2.009 Note Note: See Chapter 206, Laws of 1981 sections 29 and 31.

CSB 2.009 History History: Cr. Register, June, 1973, No. 210, eff. 7-1-73.

CSB 2.009 Note CSB 2.02 Addition of benzphetamine, chlorphentermine, clortermine, mazindol, and phendimetrazine to schedule III. The substances known as benzphetamine, chlorphentermine, clortermine, mazindol, and phendimetrazine are hereby added to s. 161.18, Stats., schedule III in sub. (2m) (a), (b), (c), (d) and (e) respectively, which subsections are created to read:

CSB 2.009 Note (2m) Any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:

CSB 2.009 Note (a) Benzphetamine

CSB 2.009 Note (b) Chlorphentermine

CSB 2.009 Note (c) Clortermine

CSB 2.009 Note (d) Mazindol

CSB 2.009 Note (e) Phendimetrazine

CSB 2.009 History History: Cr. Register, October, 1973, No. 214, eff. 11-1-73.

CSB 2.009 Note CSB 2.03 Addition of fenfluramine to schedule IV. The substance known as fenfluramine is hereby added to s. 161.20, Stats., schedule IV in sub. (2m) (a), which subsection is hereby created to read:

CSB 2.009 Note (2m) Any material, compound, mixture, or preparation which contains any quantity of the following substances having a potential for abuse associated with a stimulant effect on the central nervous system:

CSB 2.009 Note (a) Fenfluramine:

CSB 2.009 Note Note: See Chapter 206, Laws of 1981 section 47.

CSB 2.009 History History: Cr. Register, October, 1973, No. 214, eff. 11-1-73.

CSB 2.009 Note CSB 2.04 Addition of amobarbital, pentobarbital, and secobarbital to schedule II; retention of certain forms of amobarbital, pentobarbital and secobarbital in schedule III. (1) Subsection (7) of s. 161.16, Stats., schedule II is hereby created to read as follows:

CSB 2.009 Note (7) Unless excepted under federal regulations or listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances:

CSB 2.009 Note (a) Amobarbital

CSB 2.009 Note (b) Pentobarbital

CSB 2.009 Note (c) Secobarbital

CSB 2.009 Note (2) Paragraphs (m) and (n) of sub. (3), s. 161.18, Stats., schedule III, are hereby created to read as follows:

CSB 2.009 Note (m) Unless excepted under federal regulations, any compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.